Symkevi Read about Symkevi, which combines ivacaftor with tezacaftor, and find out how the drug could help to treat people with cystic fibrosis (CF).
Orkambi Orkambi (ivacaftor/lumacaftor) is the second precision medicine to be licensed for use in the UK by people with cystic fibrosis (CF).
Kalydeco Kalydeco is the first precision medicine for cystic fibrosis (CF) to be made available on the NHS.
Life-saving drugs campaign timeline Take a look at the latest updates in our campaign for fairer access to precision medicines in the UK for people with cystic fibrosis (CF).
Fighting for life-saving drugs Find out more about our campaign to make life-saving drugs available to people with cystic fibrosis (CF)
Support our campaigns We are here to shout loud and campaign hard for better care and services for people with cystic fibrosis (CF) - join us!
Your support changes lives Take a look at how your support this Christmas is helping to fund ground-breaking cystic fibrosis research.
